| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cyclosporin A binding | PPIAL4C PPIAL4D PPIAL4H PPIA PPIAL4F PPIAL4E PPIAL4A PPIAL4G | 3.30e-13 | 24 | 106 | 8 | GO:0016018 |
| GeneOntologyMolecularFunction | peptidyl-prolyl cis-trans isomerase activity | PPIAL4C PPIAL4D PPIAL4H PPIA PPIAL4F PPIAL4E PPIAL4A PPIAL4G | 2.15e-10 | 50 | 106 | 8 | GO:0003755 |
| GeneOntologyMolecularFunction | cis-trans isomerase activity | PPIAL4C PPIAL4D PPIAL4H PPIA PPIAL4F PPIAL4E PPIAL4A PPIAL4G | 3.51e-10 | 53 | 106 | 8 | GO:0016859 |
| GeneOntologyMolecularFunction | amide binding | PPIAL4C PPIAL4D PPIAL4H PPIA PPIAL4F PPIAL4E PPIAL4A PNPLA3 TAF1 PPIAL4G | 4.37e-06 | 299 | 106 | 10 | GO:0033218 |
| GeneOntologyMolecularFunction | isomerase activity | PPIAL4C PPIAL4D PPIAL4H PPIA PPIAL4F PPIAL4E PPIAL4A PPIAL4G | 8.52e-06 | 192 | 106 | 8 | GO:0016853 |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 6.52e-05 | 188 | 106 | 7 | GO:0005201 | |
| GeneOntologyMolecularFunction | polypeptide N-acetylgalactosaminyltransferase activity | 1.55e-04 | 20 | 106 | 3 | GO:0004653 | |
| GeneOntologyMolecularFunction | H3K27me3 modified histone binding | 2.76e-04 | 5 | 106 | 2 | GO:0061628 | |
| GeneOntologyMolecularFunction | pre-mRNA 3'-splice site binding | 5.76e-04 | 7 | 106 | 2 | GO:0030628 | |
| GeneOntologyMolecularFunction | acylglycerol O-acyltransferase activity | 6.45e-04 | 32 | 106 | 3 | GO:0016411 | |
| GeneOntologyMolecularFunction | diacylglycerol O-acyltransferase activity | 7.66e-04 | 8 | 106 | 2 | GO:0004144 | |
| GeneOntologyMolecularFunction | 2-acylglycerol O-acyltransferase activity | 7.66e-04 | 8 | 106 | 2 | GO:0003846 | |
| GeneOntologyMolecularFunction | acyltransferase activity | RNF112 RNF213 FBXO22 RNF103 DGAT2 SH3RF2 PNPLA3 TAF1 HADHB ZBED1 TAF1L MOGAT3 | 8.36e-04 | 775 | 106 | 12 | GO:0016746 |
| GeneOntologyMolecularFunction | acetylgalactosaminyltransferase activity | 8.41e-04 | 35 | 106 | 3 | GO:0008376 | |
| GeneOntologyMolecularFunction | RNA polymerase I general transcription initiation factor activity | 9.81e-04 | 9 | 106 | 2 | GO:0001181 | |
| GeneOntologyMolecularFunction | acyltransferase activity, transferring groups other than amino-acyl groups | 1.70e-03 | 238 | 106 | 6 | GO:0016747 | |
| GeneOntologyMolecularFunction | extracellular matrix constituent conferring elasticity | 1.78e-03 | 12 | 106 | 2 | GO:0030023 | |
| GeneOntologyMolecularFunction | prostanoid receptor activity | 1.78e-03 | 12 | 106 | 2 | GO:0004954 | |
| GeneOntologyBiologicalProcess | protein peptidyl-prolyl isomerization | PPIAL4C PPIAL4D PPIAL4H PPIA PPIAL4F PPIAL4E PPIAL4A PPIAL4G | 1.86e-11 | 38 | 108 | 8 | GO:0000413 |
| GeneOntologyBiologicalProcess | peptidyl-proline modification | PPIAL4C PPIAL4D PPIAL4H PPIA PPIAL4F PPIAL4E PPIAL4A PPIAL4G | 3.70e-10 | 54 | 108 | 8 | GO:0018208 |
| GeneOntologyBiologicalProcess | regulation of osteoclast development | 3.84e-05 | 13 | 108 | 3 | GO:2001204 | |
| GeneOntologyBiologicalProcess | protein folding | PPIAL4C PPIAL4D PPIAL4H PPIA PPIAL4F PPIAL4E PPIAL4A PPIAL4G | 4.61e-05 | 246 | 108 | 8 | GO:0006457 |
| GeneOntologyBiologicalProcess | peptidyl-amino acid modification | GALNTL6 RELN PPIAL4C PPIAL4D PPIAL4H PPIA PPIAL4F PPIAL4E PPIAL4A TAF1 GALNT6 MAPK7 ZBED1 PPIAL4G INPP5J AGTPBP1 | 4.75e-05 | 976 | 108 | 16 | GO:0018193 |
| GeneOntologyBiologicalProcess | lipid droplet organization | 5.08e-05 | 39 | 108 | 4 | GO:0034389 | |
| GeneOntologyCellularComponent | extracellular matrix | LAMB4 RELN ADAM19 CILP CLIC3 LAMA2 LAMC1 MUC5B FBN1 LTBP2 PLG FBN3 | 1.35e-04 | 656 | 107 | 12 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | LAMB4 RELN ADAM19 CILP CLIC3 LAMA2 LAMC1 MUC5B FBN1 LTBP2 PLG FBN3 | 1.39e-04 | 658 | 107 | 12 | GO:0030312 |
| GeneOntologyCellularComponent | perinuclear endoplasmic reticulum membrane | 1.55e-04 | 4 | 107 | 2 | GO:1990578 | |
| GeneOntologyCellularComponent | U2AF complex | 5.36e-04 | 7 | 107 | 2 | GO:0089701 | |
| Domain | EGF_1 | CNTNAP3B LAMB4 RELN ADAM19 CNTNAP3 NOTCH2NLA LAMA2 LAMC1 ADAM29 NOTCH2NLC FBN1 TENM3 LTBP2 FBN3 NOTCH2 | 1.32e-11 | 255 | 105 | 15 | PS00022 |
| Domain | EGF_2 | CNTNAP3B LAMB4 RELN ADAM19 CNTNAP3 NOTCH2NLA LAMA2 LAMC1 ADAM29 NOTCH2NLC FBN1 TENM3 LTBP2 FBN3 NOTCH2 | 2.28e-11 | 265 | 105 | 15 | PS01186 |
| Domain | EGF-like_dom | CNTNAP3B RELN ADAM19 CNTNAP3 NOTCH2NLA LAMA2 LAMC1 ADAM29 NOTCH2NLC FBN1 TENM3 LTBP2 FBN3 NOTCH2 | 1.21e-10 | 249 | 105 | 14 | IPR000742 |
| Domain | EGF-like_CS | LAMB4 RELN ADAM19 CNTNAP3 NOTCH2NLA LAMA2 LAMC1 ADAM29 NOTCH2NLC FBN1 TENM3 LTBP2 FBN3 NOTCH2 | 2.26e-10 | 261 | 105 | 14 | IPR013032 |
| Domain | Cyclophilin-type_PPIase_CS | 6.99e-10 | 19 | 105 | 6 | IPR020892 | |
| Domain | Cyclophilin-type_PPIase | 1.38e-09 | 21 | 105 | 6 | IPR024936 | |
| Domain | Cyclophilin-like_dom | 1.90e-09 | 22 | 105 | 6 | IPR029000 | |
| Domain | CSA_PPIASE_2 | 1.90e-09 | 22 | 105 | 6 | PS50072 | |
| Domain | Pro_isomerase | 1.90e-09 | 22 | 105 | 6 | PF00160 | |
| Domain | - | 1.90e-09 | 22 | 105 | 6 | 2.40.100.10 | |
| Domain | Cyclophilin-type_PPIase_dom | 1.90e-09 | 22 | 105 | 6 | IPR002130 | |
| Domain | CSA_PPIASE_1 | 1.90e-09 | 22 | 105 | 6 | PS00170 | |
| Domain | EGF_3 | CNTNAP3B RELN ADAM19 CNTNAP3 NOTCH2NLA ADAM29 NOTCH2NLC FBN1 TENM3 LTBP2 FBN3 NOTCH2 | 8.27e-09 | 235 | 105 | 12 | PS50026 |
| Domain | EGF | CNTNAP3B RELN CNTNAP3 NOTCH2NLA LAMA2 LAMC1 NOTCH2NLC FBN1 TENM3 LTBP2 FBN3 NOTCH2 | 8.27e-09 | 235 | 105 | 12 | SM00181 |
| Domain | TB | 5.94e-06 | 7 | 105 | 3 | PF00683 | |
| Domain | EGF_CA | 8.93e-06 | 86 | 105 | 6 | PF07645 | |
| Domain | - | 9.47e-06 | 8 | 105 | 3 | 3.90.290.10 | |
| Domain | TB | 1.42e-05 | 9 | 105 | 3 | PS51364 | |
| Domain | TB_dom | 1.42e-05 | 9 | 105 | 3 | IPR017878 | |
| Domain | EGF_Ca-bd_CS | 1.79e-05 | 97 | 105 | 6 | IPR018097 | |
| Domain | EGF_CA | 2.01e-05 | 99 | 105 | 6 | PS01187 | |
| Domain | ASX_HYDROXYL | 2.12e-05 | 100 | 105 | 6 | PS00010 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 2.96e-05 | 106 | 105 | 6 | IPR000152 | |
| Domain | TAF_II_230-bd | 3.13e-05 | 2 | 105 | 2 | IPR009067 | |
| Domain | TFIID_sub1_DUF3591 | 3.13e-05 | 2 | 105 | 2 | IPR022591 | |
| Domain | - | 3.13e-05 | 2 | 105 | 2 | 1.10.1100.10 | |
| Domain | TBP-binding | 3.13e-05 | 2 | 105 | 2 | PF09247 | |
| Domain | DUF3591 | 3.13e-05 | 2 | 105 | 2 | PF12157 | |
| Domain | TAF1_animal | 3.13e-05 | 2 | 105 | 2 | IPR011177 | |
| Domain | EGF_CA | 6.52e-05 | 122 | 105 | 6 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 7.14e-05 | 124 | 105 | 6 | IPR001881 | |
| Domain | EGF | 7.80e-05 | 126 | 105 | 6 | PF00008 | |
| Domain | Laminin_N | 9.17e-05 | 16 | 105 | 3 | IPR008211 | |
| Domain | LAMININ_NTER | 9.17e-05 | 16 | 105 | 3 | PS51117 | |
| Domain | Laminin_N | 9.17e-05 | 16 | 105 | 3 | PF00055 | |
| Domain | LamNT | 9.17e-05 | 16 | 105 | 3 | SM00136 | |
| Domain | FBN | 9.36e-05 | 3 | 105 | 2 | IPR011398 | |
| Domain | U2AF_small | 3.10e-04 | 5 | 105 | 2 | IPR009145 | |
| Domain | EGF_extracell | 3.61e-04 | 60 | 105 | 4 | IPR013111 | |
| Domain | EGF_2 | 3.61e-04 | 60 | 105 | 4 | PF07974 | |
| Domain | Ricin_B_lectin | 3.63e-04 | 25 | 105 | 3 | PF00652 | |
| Domain | WxxW_domain | 4.63e-04 | 6 | 105 | 2 | IPR025155 | |
| Domain | Mucin2_WxxW | 4.63e-04 | 6 | 105 | 2 | PF13330 | |
| Domain | RICIN | 5.11e-04 | 28 | 105 | 3 | SM00458 | |
| Domain | RICIN_B_LECTIN | 5.11e-04 | 28 | 105 | 3 | PS50231 | |
| Domain | Ricin_B_lectin | 6.28e-04 | 30 | 105 | 3 | IPR000772 | |
| Domain | Glycos_transf_2 | 6.28e-04 | 30 | 105 | 3 | PF00535 | |
| Domain | EGF_LAM_2 | 6.28e-04 | 30 | 105 | 3 | PS50027 | |
| Domain | Glyco_trans_2-like | 6.28e-04 | 30 | 105 | 3 | IPR001173 | |
| Domain | EGF_LAM_1 | 6.28e-04 | 30 | 105 | 3 | PS01248 | |
| Domain | DAGAT | 6.45e-04 | 7 | 105 | 2 | PF03982 | |
| Domain | DAGAT | 6.45e-04 | 7 | 105 | 2 | IPR007130 | |
| Domain | Prostanoid_rcpt | 8.57e-04 | 8 | 105 | 2 | IPR008365 | |
| Domain | LAMININ_IVA | 8.57e-04 | 8 | 105 | 2 | PS51115 | |
| Domain | Laminin_B | 8.57e-04 | 8 | 105 | 2 | PF00052 | |
| Domain | LamB | 8.57e-04 | 8 | 105 | 2 | SM00281 | |
| Domain | Laminin_IV | 8.57e-04 | 8 | 105 | 2 | IPR000034 | |
| Domain | Laminin_EGF | 9.91e-04 | 35 | 105 | 3 | PF00053 | |
| Domain | EGF_Lam | 9.91e-04 | 35 | 105 | 3 | SM00180 | |
| Domain | LAM_G_DOMAIN | 1.26e-03 | 38 | 105 | 3 | PS50025 | |
| Domain | Laminin_EGF | 1.26e-03 | 38 | 105 | 3 | IPR002049 | |
| Domain | Laminin_G_2 | 1.47e-03 | 40 | 105 | 3 | PF02210 | |
| Domain | Growth_fac_rcpt_ | 1.88e-03 | 156 | 105 | 5 | IPR009030 | |
| Domain | LamG | 1.93e-03 | 44 | 105 | 3 | SM00282 | |
| Domain | Galactose-bd-like | 1.95e-03 | 94 | 105 | 4 | IPR008979 | |
| Domain | Disintegrin_CS | 3.57e-03 | 16 | 105 | 2 | IPR018358 | |
| Domain | CarboxyPept-like_regulatory | 4.03e-03 | 17 | 105 | 2 | IPR008969 | |
| Domain | Laminin_G | 4.26e-03 | 58 | 105 | 3 | IPR001791 | |
| Domain | ADAM_CR | 4.52e-03 | 18 | 105 | 2 | PF08516 | |
| Domain | - | 5.57e-03 | 20 | 105 | 2 | 4.10.70.10 | |
| Pubmed | Evolution of Human Brain Size-Associated NOTCH2NL Genes Proceeds toward Reduced Protein Levels. | 1.16e-07 | 4 | 108 | 3 | 32330268 | |
| Pubmed | Human-Specific NOTCH2NL Genes Affect Notch Signaling and Cortical Neurogenesis. | 2.90e-07 | 5 | 108 | 3 | 29856954 | |
| Pubmed | 1.61e-06 | 8 | 108 | 3 | 9852162 | ||
| Pubmed | Requirement of tissue-selective TBP-associated factor TAFII105 in ovarian development. | 8.14e-06 | 13 | 108 | 3 | 11557891 | |
| Pubmed | Shared and specific signatures of locomotor ataxia in mutant mice. | 9.55e-06 | 2 | 108 | 2 | 32718435 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 26807827 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 38804708 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 22842574 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 27571988 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 34403156 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 32116123 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 24867584 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 31150793 | ||
| Pubmed | IMPDH2 Is an Intracellular Target of the Cyclophilin A and Sanglifehrin A Complex. | 9.55e-06 | 2 | 108 | 2 | 28076787 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 15221638 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 10070062 | ||
| Pubmed | Reelin and aromatase cooperate in ovarian follicle development. | 9.55e-06 | 2 | 108 | 2 | 29880879 | |
| Pubmed | Cleavage of sphingosine kinase 2 by caspase-1 provokes its release from apoptotic cells. | 9.55e-06 | 2 | 108 | 2 | 20197547 | |
| Pubmed | Protein interactome reveals converging molecular pathways among autism disorders. | IMPDH2 NOTCH2NLA LAMC1 WDR74 FBN1 AHCY CHRD PEX5 MAPK7 NOTCH2 | 1.02e-05 | 560 | 108 | 10 | 21653829 |
| Pubmed | 1.03e-05 | 14 | 108 | 3 | 16873583 | ||
| Pubmed | Glycoproteomics Reveals Decorin Peptides With Anti-Myostatin Activity in Human Atrial Fibrillation. | 1.35e-05 | 97 | 108 | 5 | 27559042 | |
| Pubmed | 1.43e-05 | 167 | 108 | 6 | 22159717 | ||
| Pubmed | 1.86e-05 | 175 | 108 | 6 | 28071719 | ||
| Pubmed | 2.30e-05 | 18 | 108 | 3 | 11311202 | ||
| Pubmed | Angiomotin regulates endothelial cell-cell junctions and cell motility. | 2.86e-05 | 3 | 108 | 2 | 16043488 | |
| Pubmed | Characterization of U2AF(6), a splicing factor related to U2AF(35). | 2.86e-05 | 3 | 108 | 2 | 11739736 | |
| Pubmed | Expression of laminin chains during myogenic differentiation. | 2.86e-05 | 3 | 108 | 2 | 7510707 | |
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 16822332 | ||
| Pubmed | TAFII55 binding to TAFII250 inhibits its acetyltransferase activity. | 2.86e-05 | 3 | 108 | 2 | 11592977 | |
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 17293099 | ||
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 12217962 | ||
| Pubmed | TAF7: a possible transcription initiation check-point regulator. | 2.86e-05 | 3 | 108 | 2 | 16407123 | |
| Pubmed | 4.30e-05 | 22 | 108 | 3 | 18448648 | ||
| Pubmed | 5.71e-05 | 4 | 108 | 2 | 8395631 | ||
| Pubmed | 5.71e-05 | 4 | 108 | 2 | 21540769 | ||
| Pubmed | 5.71e-05 | 4 | 108 | 2 | 20514852 | ||
| Pubmed | 5.71e-05 | 4 | 108 | 2 | 29561261 | ||
| Pubmed | Heparin/heparan sulfate controls fibrillin-1, -2 and -3 self-interactions in microfibril assembly. | 5.71e-05 | 4 | 108 | 2 | 25034023 | |
| Pubmed | 5.71e-05 | 4 | 108 | 2 | 12788892 | ||
| Pubmed | 5.71e-05 | 4 | 108 | 2 | 14638863 | ||
| Pubmed | 5.71e-05 | 4 | 108 | 2 | 15925391 | ||
| Pubmed | 5.71e-05 | 4 | 108 | 2 | 2707487 | ||
| Pubmed | Biochemical characterization of human acyl coenzyme A: 2-monoacylglycerol acyltransferase-3 (MGAT3). | 5.71e-05 | 4 | 108 | 2 | 27184406 | |
| Pubmed | 5.71e-05 | 4 | 108 | 2 | 20301293 | ||
| Pubmed | 5.71e-05 | 4 | 108 | 2 | 8013566 | ||
| Pubmed | 5.71e-05 | 4 | 108 | 2 | 8326827 | ||
| Pubmed | 9.50e-05 | 5 | 108 | 2 | 11969289 | ||
| Pubmed | A critical function of the pial basement membrane in cortical histogenesis. | 9.50e-05 | 5 | 108 | 2 | 12122064 | |
| Pubmed | Expression of laminin isoforms in mouse myogenic cells in vitro and in vivo. | 9.50e-05 | 5 | 108 | 2 | 8719886 | |
| Pubmed | Human-Specific NOTCH2NL Genes Expand Cortical Neurogenesis through Delta/Notch Regulation. | 9.50e-05 | 5 | 108 | 2 | 29856955 | |
| Pubmed | MAGI1 as a link between endothelial activation and ER stress drives atherosclerosis. | 9.50e-05 | 5 | 108 | 2 | 30944250 | |
| Pubmed | 9.50e-05 | 5 | 108 | 2 | 28636612 | ||
| Pubmed | 9.50e-05 | 5 | 108 | 2 | 18197264 | ||
| Pubmed | Laminin alpha 2 chain (M chain) is found within the pathway of avian and murine retinal projections. | 9.50e-05 | 5 | 108 | 2 | 8613743 | |
| Pubmed | 9.58e-05 | 146 | 108 | 5 | 27068509 | ||
| Pubmed | 1.11e-04 | 30 | 108 | 3 | 38636517 | ||
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | PPIAL4C CILP KRT84 GRB2 LAMC1 MUC5B GALNT7 PPIA AHCY PPIAL4A LTBP2 PLG | 1.25e-04 | 1070 | 108 | 12 | 23533145 |
| Pubmed | 1.42e-04 | 6 | 108 | 2 | 1678389 | ||
| Pubmed | Interaction between Reelin and Notch signaling regulates neuronal migration in the cerebral cortex. | 1.42e-04 | 6 | 108 | 2 | 18957219 | |
| Pubmed | 1.42e-04 | 6 | 108 | 2 | 11054877 | ||
| Pubmed | In trans neuregulin3-Caspr3 interaction controls DA axonal bassoon cluster development. | 1.42e-04 | 6 | 108 | 2 | 34143959 | |
| Pubmed | 1.42e-04 | 6 | 108 | 2 | 26555376 | ||
| Pubmed | 1.42e-04 | 6 | 108 | 2 | 19959467 | ||
| Pubmed | Effect of basement membrane entactin on epidermal cell attachment and growth. | 1.42e-04 | 6 | 108 | 2 | 3794389 | |
| Pubmed | Laminin regulates PDGFRβ(+) cell stemness and muscle development. | 1.42e-04 | 6 | 108 | 2 | 27138650 | |
| Pubmed | The timing of cortical neurogenesis is encoded within lineages of individual progenitor cells. | 1.42e-04 | 6 | 108 | 2 | 16680166 | |
| Pubmed | Laminin-nidogen complex. Extraction with chelating agents and structural characterization. | 1.42e-04 | 6 | 108 | 2 | 3109910 | |
| Pubmed | Structural elucidation of full-length nidogen and the laminin-nidogen complex in solution. | 1.42e-04 | 6 | 108 | 2 | 23948589 | |
| Pubmed | 1.42e-04 | 6 | 108 | 2 | 2119632 | ||
| Pubmed | Synthesis of neutral ether lipid monoalkyl-diacylglycerol by lipid acyltransferases. | 1.42e-04 | 6 | 108 | 2 | 28420705 | |
| Pubmed | 1.42e-04 | 6 | 108 | 2 | 12387869 | ||
| Pubmed | 1.42e-04 | 6 | 108 | 2 | 19182256 | ||
| Pubmed | Autophagosomal Content Profiling Reveals an LC3C-Dependent Piecemeal Mitophagy Pathway. | 1.48e-04 | 33 | 108 | 3 | 29149599 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | ZNF143 PPIAL4D U2AF1L4 PPIA PPIAL4F U2AF1 PHF3 PPIAL4A TAF1 PPIAL4G TAF1L | 1.92e-04 | 954 | 108 | 11 | 36373674 |
| Pubmed | 1.99e-04 | 7 | 108 | 2 | 10848613 | ||
| Pubmed | Abscence of laminin alpha1 chain in the skeletal muscle of dystrophic dy/dy mice. | 1.99e-04 | 7 | 108 | 2 | 9390664 | |
| Pubmed | 1.99e-04 | 7 | 108 | 2 | 17301088 | ||
| Pubmed | Mapping of the murine tbl1 gene reveals a new rearrangement between mouse and human X Chromosomes. | 1.99e-04 | 7 | 108 | 2 | 9880679 | |
| Pubmed | 1.99e-04 | 7 | 108 | 2 | 14557481 | ||
| Pubmed | 1.99e-04 | 7 | 108 | 2 | 26018088 | ||
| Pubmed | 2.64e-04 | 99 | 108 | 4 | 34161765 | ||
| Pubmed | EMILIN proteins are novel extracellular constituents of the dentin-pulp complex. | 2.64e-04 | 8 | 108 | 2 | 32948785 | |
| Pubmed | Genomic organization of the DGAT2/MOGAT gene family in cattle (Bos taurus) and other mammals. | 2.64e-04 | 8 | 108 | 2 | 14970677 | |
| Pubmed | Prostanoid receptors: structures, properties, and functions. | 2.64e-04 | 8 | 108 | 2 | 10508233 | |
| Pubmed | Dual roles of PGE2-EP4 signaling in mouse experimental autoimmune encephalomyelitis. | 2.64e-04 | 8 | 108 | 2 | 20566843 | |
| Pubmed | Genetic mapping in the region of the mouse X-inactivation center. | 2.64e-04 | 8 | 108 | 2 | 1974879 | |
| Pubmed | 2.64e-04 | 8 | 108 | 2 | 8872465 | ||
| Pubmed | 2.64e-04 | 8 | 108 | 2 | 2230805 | ||
| Pubmed | High-density molecular map of the central span of the mouse X chromosome. | 2.64e-04 | 8 | 108 | 2 | 1675191 | |
| Pubmed | Conservation of position and exclusive expression of mouse Xist from the inactive X chromosome. | 2.64e-04 | 8 | 108 | 2 | 2034279 | |
| Pubmed | Rescue of ataxia and preplate splitting by ectopic expression of Reelin in reeler mice. | 2.64e-04 | 8 | 108 | 2 | 11856531 | |
| Pubmed | Thromboxane A2 and prostaglandin F2alpha mediate inflammatory tachycardia. | 2.64e-04 | 8 | 108 | 2 | 15834430 | |
| Pubmed | 2.64e-04 | 8 | 108 | 2 | 12019269 | ||
| Pubmed | 2.64e-04 | 8 | 108 | 2 | 11927615 | ||
| Pubmed | Association between polymorphisms in prostanoid receptor genes and aspirin-intolerant asthma. | 2.64e-04 | 8 | 108 | 2 | 17496729 | |
| Pubmed | Physical mapping of 2000 kb of the mouse X chromosome in the vicinity of the Xist locus. | 2.64e-04 | 8 | 108 | 2 | 8468051 | |
| Pubmed | Deletion of Prl7d1 causes placental defects at mid-pregnancy in mice. | 2.64e-04 | 8 | 108 | 2 | 31012985 | |
| Pubmed | 2.64e-04 | 8 | 108 | 2 | 19966781 | ||
| Pubmed | 3.39e-04 | 9 | 108 | 2 | 12665565 | ||
| Pubmed | 3.39e-04 | 9 | 108 | 2 | 2293612 | ||
| Cytoband | 1q21.2 | 7.21e-07 | 71 | 107 | 5 | 1q21.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q21 | PPIAL4C PPIAL4D PPIAL4H NOTCH2NLA NOTCH2NLC PPIAL4F PPIAL4E PPIAL4G | 5.12e-06 | 404 | 107 | 8 | chr1q21 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4q34 | 1.31e-05 | 61 | 107 | 4 | chr4q34 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q25 | 7.89e-04 | 307 | 107 | 5 | chr17q25 | |
| Cytoband | 17q25.3 | 1.74e-03 | 101 | 107 | 3 | 17q25.3 | |
| GeneFamily | Laminin subunits | 9.53e-06 | 12 | 65 | 3 | 626 | |
| GeneFamily | Polypeptide N-acetylgalactosaminyltransferases | 4.84e-05 | 20 | 65 | 3 | 433 | |
| GeneFamily | Diacylglycerol O-acyltransferase 2 family | 3.51e-04 | 8 | 65 | 2 | 1235 | |
| GeneFamily | Prostaglandin (prostanoid) receptors | 4.51e-04 | 9 | 65 | 2 | 207 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 4.22e-03 | 27 | 65 | 2 | 47 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 9.45e-07 | 196 | 101 | 8 | M3008 | |
| Coexpression | NABA_CORE_MATRISOME | 1.15e-05 | 275 | 101 | 8 | M5884 | |
| ToppCell | Bronchial-10x5prime-Stromal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.89e-07 | 200 | 108 | 7 | 5ea12e17f50fefbf5534e487af3392b2fa2d13ad | |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_adventitial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.89e-07 | 200 | 108 | 7 | b04831708fa20471a127b87e8db3728b6e729ce8 | |
| ToppCell | (5)_Epithelial_cells-(5)_Glands_mucous|(5)_Epithelial_cells / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 5.15e-06 | 180 | 108 | 6 | a4118adaf4b09e2ca01b662ed60e7bbf32a24d58 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.66e-06 | 183 | 108 | 6 | 4d16bfbadf2cd13008c35e23dd2b5b4ecf92ee11 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.21e-06 | 186 | 108 | 6 | 40070d9cd20188ba49b32acfca9bc16256b38bf5 | |
| ToppCell | LA-01._Fibroblast_I|World / Chamber and Cluster_Paper | 6.40e-06 | 187 | 108 | 6 | 4ea486991f66c29728d127171a07b81404ec0b78 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.23e-06 | 191 | 108 | 6 | b7a57691a4742070cee640e285c1f4d0da95baf1 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.67e-06 | 193 | 108 | 6 | b05361ffe111a38cfa26eb86e4ae62c15ac99b7b | |
| ToppCell | LA|World / Chamber and Cluster_Paper | 7.67e-06 | 193 | 108 | 6 | d4bf89437216baf489ea0239136dcedf3b6714af | |
| ToppCell | COVID-19-Heart-Fib_2|Heart / Disease (COVID-19 only), tissue and cell type | 7.90e-06 | 194 | 108 | 6 | d91c9f2ec47319051fc398320693fddbe8bbd4d6 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.14e-06 | 195 | 108 | 6 | 1236dc60288c7dd91868e86e9174a2dacd3b11b3 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.62e-06 | 197 | 108 | 6 | 71786e9432e2d649f5d86f639abb25e7102deb67 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Perivascular_fibroblast|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.13e-06 | 199 | 108 | 6 | dfc5c7a4a093baa7158dd8d4d29a870d9c469a3f | |
| ToppCell | distal-2-mesenchymal-Adventitial_Fibroblast|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 9.13e-06 | 199 | 108 | 6 | 97b475f9110ef7bb29d9cf2109b7e43177830f05 | |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 9.13e-06 | 199 | 108 | 6 | e1f1950d6f840485e263b83dc81b98910be3ae7a | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.13e-06 | 199 | 108 | 6 | 0019cfaa586a450c2e4952d1184a540561c8d0ba | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Perivascular_fibroblast-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.13e-06 | 199 | 108 | 6 | c1760581c34b81d1d92c67500a1c8944e9cc6dad | |
| ToppCell | Biopsy_Control_(H.)-Mesenchymal-Fibroblasts|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 9.40e-06 | 200 | 108 | 6 | 8d75ce89393df452defacf2ec9a5bd4b7708afbb | |
| ToppCell | Bronchus_Control_(B.)-Stromal-TX-Fibroblasts-2,_SCARA5|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 9.40e-06 | 200 | 108 | 6 | 2022df85df94ab8cbb4e80e3fe9894c01051c5e0 | |
| ToppCell | 5'-Adult-Distal_Rectal-Mesenchymal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.40e-06 | 200 | 108 | 6 | db6281b5d4032116310db379d9175d790994c99c | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.40e-06 | 200 | 108 | 6 | 3e6730c9ed7003a4acf501f699a4965a7a50f946 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.40e-06 | 200 | 108 | 6 | ba5ed66b05caa1be0bbf8d54c4e72a782b8d9833 | |
| ToppCell | Bronchus_Control_(B.)-Stromal-TX|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 9.40e-06 | 200 | 108 | 6 | 69b41f5fb370aa8840a9ad7919d03ef1e57d1b5b | |
| ToppCell | 5'-Adult-Distal_Rectal-Mesenchymal-fibroblastic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.40e-06 | 200 | 108 | 6 | 10f0c20ba7c71d9e2e177597f85b41cb40f0d878 | |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 9.40e-06 | 200 | 108 | 6 | 6316c288022719b9e6c4332c5cb9041e1188d0e8 | |
| ToppCell | 5'-Adult-Distal_Rectal-Mesenchymal-fibroblastic-Transitional_Stromal_3_(C3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.40e-06 | 200 | 108 | 6 | a2bb67a06757f19be3f56f8cb5bb7e2affa5f4ed | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_myofibroblast|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 9.40e-06 | 200 | 108 | 6 | 54806080b5e97859ee6a4a9b4f19e22021c218f5 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.40e-06 | 200 | 108 | 6 | 5a87bb8eb1c6bd2fbc357e1528e15ba1c0051438 | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocyte.Tnr.Cyth3_(Cyth3)-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 3.58e-05 | 153 | 108 | 5 | 553dff9688a1996d8f4ba16e60c683593d781389 | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocyte.Tnr.Cyth3_(Cyth3)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 3.58e-05 | 153 | 108 | 5 | 88ca2d2c2ab19fbee13e18951b993ee05dd30f67 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.57e-05 | 161 | 108 | 5 | 7c9d4410d7142a5f3a05418c994f69978c9ffa17 | |
| ToppCell | Adult-Mesenchymal-chondrocyte-D231|Adult / Lineage, Cell type, age group and donor | 4.98e-05 | 164 | 108 | 5 | 2ba57dce5f69a88f0d1e450b9780425e2d9ca7d4 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.28e-05 | 166 | 108 | 5 | 60060b03f2abfa3cc08107ab5a9f578e60e4ae16 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.28e-05 | 166 | 108 | 5 | ec9161d388db5a257b8d125c14f9dd911d5d5d4a | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)-|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.28e-05 | 166 | 108 | 5 | 4586d6725403f879fc96f67be579022587ce1906 | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma-4|TCGA-Lung / Sample_Type by Project: Shred V9 | 5.59e-05 | 168 | 108 | 5 | aefea14b8b1c1b6a05f827effd22ba15274fddc9 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.75e-05 | 169 | 108 | 5 | 031465190cd3623a25ef2b868daab8d932c8ff08 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.08e-05 | 171 | 108 | 5 | 15cb4670ff4234ac46aea8a5911138d6913c4482 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_lymph_vessel-D122|Adult / Lineage, Cell type, age group and donor | 6.42e-05 | 173 | 108 | 5 | dba09ba9748871e38a16449d500ae4d7b405c42f | |
| ToppCell | 3'-Airway_Nasal_SMG-Epithelial-Epithelial_transtional-secretory-SMG_mucus_secreting_cell-SMG_mucous-SMG_mucous_L.0.6.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.60e-05 | 174 | 108 | 5 | b1b54e4e23df8cfc04bf298d5c53de203a38b267 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 7.15e-05 | 177 | 108 | 5 | cdfd2f0ee2f692271b1525e414b0f645cdadb1f6 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)|356C / Donor, Lineage, Cell class and subclass (all cells) | 7.15e-05 | 177 | 108 | 5 | db222faaecbe5600da39277243c4e7e764eb63c9 | |
| ToppCell | 3'-Broncho-tracheal_SMG-Epithelial-Epithelial_transtional-secretory-SMG_mucus_secreting_cell-SMG_mucous-SMG_mucous_L.0.6.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.74e-05 | 180 | 108 | 5 | 8af51245ac1269f318268f574cfaddb0b8c80a53 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.95e-05 | 181 | 108 | 5 | b116c68393d8836bac080f81a8fcbeb52e0403e7 | |
| ToppCell | 10x3'2.3-week_14-16-Endothelial-stroma-proliferating_EC|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 8.16e-05 | 182 | 108 | 5 | 997d37ca2af661c92a56add888762724dfccc890 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.16e-05 | 182 | 108 | 5 | d3a037268f026eb2f84428b1821022503cef7756 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.16e-05 | 182 | 108 | 5 | 53c267ee327e116dbd89d5927ed3bdf78d25ee62 | |
| ToppCell | FLU-Healthy-0|FLU / Virus stimulation, Condition and Cluster | 8.37e-05 | 183 | 108 | 5 | 058604ddb06b3bef131183d86b83b422dae8f6cb | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.37e-05 | 183 | 108 | 5 | 121791ef84e7ce377ed6f5b7953af8865e04958e | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.37e-05 | 183 | 108 | 5 | 04d3cc76038b8192c915f1c08c3e26f2ad3b3779 | |
| ToppCell | FLU-Healthy-0|Healthy / Virus stimulation, Condition and Cluster | 8.37e-05 | 183 | 108 | 5 | 7a6f18246c39864479e114f698581f667fa9c600 | |
| ToppCell | COVID-19-Heart-Fib_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.81e-05 | 185 | 108 | 5 | 8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d | |
| ToppCell | 3'-Airway_Nasal_SMG-Epithelial-Epithelial_transtional-secretory-SMG_mucus_secreting_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.81e-05 | 185 | 108 | 5 | d9039770226338fbc3fce92aa229fad96e16db8c | |
| ToppCell | 3'-Airway_Nasal_SMG-Epithelial-Epithelial_transtional-secretory-SMG_mucus_secreting_cell-SMG_mucous|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.81e-05 | 185 | 108 | 5 | b931ab35da10e6e3877071dce9b13fc0da63dc88 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.04e-05 | 186 | 108 | 5 | 6379609b7ace80683f5754b16aa77f11b43766ae | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.50e-05 | 188 | 108 | 5 | 8de5a07301f9b5984680c873e5a92395b5ed3dd3 | |
| ToppCell | ASK454-Endothelial-Lymphatic|Endothelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 9.74e-05 | 189 | 108 | 5 | 316c857dec9383823e09f966bca62d52d933b141 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.74e-05 | 189 | 108 | 5 | d531399749409d614adca13d181830c6e3287508 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.74e-05 | 189 | 108 | 5 | 99a13b1b669b0cd36e3096632351d9ade25d1173 | |
| ToppCell | droplet-Lung-LUNG-30m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.74e-05 | 189 | 108 | 5 | 6b3b42d758b63a0df62310c34fa3bde421c1afd7 | |
| ToppCell | E18.5-samps-Mesenchymal|E18.5-samps / Age Group, Lineage, Cell class and subclass | 9.74e-05 | 189 | 108 | 5 | 0c18d3de4720759cf802eefb4d0ddde2a9246a1a | |
| ToppCell | droplet-Lung-LUNG-30m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.74e-05 | 189 | 108 | 5 | 344b23d3c47d0665dda1cd4856a5e72f1c28cfb3 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.99e-05 | 190 | 108 | 5 | 1121eb607a984c59fbffe7220837fc178745aa55 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.99e-05 | 190 | 108 | 5 | 6e6ce6dd549d1c38cfef5b3f8be06ab01ce344b7 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.99e-05 | 190 | 108 | 5 | 048b581e3f7ea9fc2f87c0532974bba85c7292c2 | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.99e-05 | 190 | 108 | 5 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.99e-05 | 190 | 108 | 5 | 8c9c230a509afaeee50644153974a5642b01a2b8 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.99e-05 | 190 | 108 | 5 | 0acf1d5da68db449d8c9e70519a236ce825f9d11 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.99e-05 | 190 | 108 | 5 | e58e4b6fbeb4368f738adac67ec10879c0966f0f | |
| ToppCell | PND07-28-samps-Mesenchymal-Myofibroblast|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.02e-04 | 191 | 108 | 5 | 9bbafdf316c1fa3a9f1ee30d41dd7158b5c97279 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.02e-04 | 191 | 108 | 5 | 0fae1c2ef9f83ac7721d0a9d69455bf97eed9257 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.02e-04 | 191 | 108 | 5 | 4e4488380379ed29d7898bae4e24221e7c67eb9d | |
| ToppCell | metastatic_Lymph_Node-Fibroblasts-Myofibroblasts|metastatic_Lymph_Node / Location, Cell class and cell subclass | 1.02e-04 | 191 | 108 | 5 | aa43b472bc8362f79ae63f09f1ca764718bbf22c | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.02e-04 | 191 | 108 | 5 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-04 | 192 | 108 | 5 | 671d4e1eee5aba03c43dbc98f4b51ce42b3df5d5 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-A|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.05e-04 | 192 | 108 | 5 | fee99ca7e658963acf968aa724ef8c96cfc00a5d | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-04 | 192 | 108 | 5 | a2c31390da4962bda9a936470b0b68fa1f5d47d1 | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.05e-04 | 192 | 108 | 5 | 7b48df661f61ce494bf6f0b9a74b0422e29c24bf | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-04 | 192 | 108 | 5 | eeab1cef7c36ae824381952c5b2c982368c379fd | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.05e-04 | 192 | 108 | 5 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.05e-04 | 192 | 108 | 5 | 32acd89617934016cd135d2cc797e8e79ae1b37f | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-04 | 192 | 108 | 5 | 840a34c1b82d218be999ab5e1bcafd6370d7a4b1 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.05e-04 | 192 | 108 | 5 | 0003d7ef9a8e521e70ac33c63aad843d9b6215c2 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.4.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.07e-04 | 193 | 108 | 5 | 5bee7abc550ddaa28cbb3b9ecaf6b924ab175de0 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-04 | 193 | 108 | 5 | d9c20a092b507c43fcf7ccb04073fecd27d1749c | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_fibro-stroma-arteriolar_fibroblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.07e-04 | 193 | 108 | 5 | 3d85c28f6ebdcb15e875ad01d52d6c138fbf8525 | |
| ToppCell | LV-02._Fibroblast_II|LV / Chamber and Cluster_Paper | 1.10e-04 | 194 | 108 | 5 | 014d2feb5db2a6a35ef759761a41e466e108c3c1 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-AC-like-AC-like-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.10e-04 | 194 | 108 | 5 | 8b81f039f5b25d35a4d5a41b27d4d9360ba22f15 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.13e-04 | 195 | 108 | 5 | f54bc4454270ff06e85596f98199372b50d0179f | |
| ToppCell | COVID-19-Heart-Fib_1|Heart / Disease (COVID-19 only), tissue and cell type | 1.13e-04 | 195 | 108 | 5 | f423baa36ac7cdc383c033e35a7d17e6bf913323 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-stromal_related|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.13e-04 | 195 | 108 | 5 | 1be9502577267ca2a04656a99d57e3e2f124d92e | |
| ToppCell | LA-02._Fibroblast_II|World / Chamber and Cluster_Paper | 1.13e-04 | 195 | 108 | 5 | a78b605b49acd8c9d68716266ca269dafcd910b9 | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 1.13e-04 | 195 | 108 | 5 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.13e-04 | 195 | 108 | 5 | a486a7acea0e91048cc48afa0dbd3926d30bc217 | |
| ToppCell | IPF-Stromal-Myofibroblast|IPF / Disease state, Lineage and Cell class | 1.16e-04 | 196 | 108 | 5 | 2d0a48e49b3b37bb66e33e74c52915911e1f8a74 | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 1.18e-04 | 197 | 108 | 5 | fb847f2277609c31fffcdf49517243ce0684facf | |
| ToppCell | CV-Severe-1|Severe / Virus stimulation, Condition and Cluster | 1.21e-04 | 198 | 108 | 5 | 9b9ee0b0f6cc92e7be94869604c98f43d57ff8ff | |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.21e-04 | 198 | 108 | 5 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.21e-04 | 198 | 108 | 5 | 8b9e8eaeffda40912a0163fdf39b93bc5e64751c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.21e-04 | 198 | 108 | 5 | a860246bcea847249a78fd2e86ed8e04371060db | |
| Drug | Mafenide hydrochloride [138-37-4]; Down 200; 18uM; MCF7; HT_HG-U133A | 2.98e-06 | 199 | 101 | 8 | 2287_DN | |
| Disease | Marfan Syndrome | 5.57e-06 | 11 | 97 | 3 | C0024796 | |
| Disease | Weill-Marchesani syndrome | 3.20e-05 | 3 | 97 | 2 | C0265313 | |
| Disease | connective tissue disease (implicated_via_orthology) | 3.20e-05 | 3 | 97 | 2 | DOID:65 (implicated_via_orthology) | |
| Disease | Weill-Marchesani Syndrome, Autosomal Dominant | 3.20e-05 | 3 | 97 | 2 | C1869115 | |
| Disease | Weill-Marchesani Syndrome, Autosomal Recessive | 3.20e-05 | 3 | 97 | 2 | C1869114 | |
| Disease | Weill-Marchesani syndrome | 6.39e-05 | 4 | 97 | 2 | cv:C0265313 | |
| Disease | Weill-Marchesani syndrome (is_implicated_in) | 6.39e-05 | 4 | 97 | 2 | DOID:0050475 (is_implicated_in) | |
| Disease | fatty liver disease (implicated_via_orthology) | 1.45e-04 | 31 | 97 | 3 | DOID:9452 (implicated_via_orthology) | |
| Disease | intraocular pressure measurement | 2.80e-04 | 509 | 97 | 8 | EFO_0004695 | |
| Disease | autosomal recessive intellectual developmental disorder (implicated_via_orthology) | 2.96e-04 | 8 | 97 | 2 | DOID:0060308 (implicated_via_orthology) | |
| Disease | Marfan Syndrome, Type I | 3.79e-04 | 9 | 97 | 2 | C4721845 | |
| Disease | octadecanedioate measurement | 4.73e-04 | 10 | 97 | 2 | EFO_0021056 | |
| Disease | coronary artery disease | CDK18 ADAM19 ETV1 ARHGEF12 FBXL17 RNF213 LAMC1 PKHD1 PNPLA3 PLG USP48 TBL1X | 5.46e-04 | 1194 | 97 | 12 | EFO_0001645 |
| Disease | pneumococcal bacteremia | 5.77e-04 | 11 | 97 | 2 | EFO_1001925 | |
| Disease | tea consumption measurement | 8.82e-04 | 129 | 97 | 4 | EFO_0010091 | |
| Disease | Tinnitus | 9.08e-04 | 130 | 97 | 4 | HP_0000360 | |
| Disease | ceramide measurement | 1.09e-03 | 235 | 97 | 5 | EFO_0010222 | |
| Disease | non-alcoholic fatty liver disease (is_implicated_in) | 1.58e-03 | 18 | 97 | 2 | DOID:0080208 (is_implicated_in) | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 1.62e-03 | 152 | 97 | 4 | DOID:0060041 (implicated_via_orthology) | |
| Disease | glaucoma | 1.70e-03 | 154 | 97 | 4 | MONDO_0005041 | |
| Disease | serum IgG glycosylation measurement | 1.72e-03 | 523 | 97 | 7 | EFO_0005193 | |
| Disease | bipolar disorder, body mass index | 1.74e-03 | 72 | 97 | 3 | EFO_0004340, MONDO_0004985 | |
| Disease | Colorectal Carcinoma | 2.22e-03 | 702 | 97 | 8 | C0009402 | |
| Disease | sphingomyelin measurement | 2.28e-03 | 278 | 97 | 5 | EFO_0010118 | |
| Disease | hypothyroidism (biomarker_via_orthology) | 2.36e-03 | 80 | 97 | 3 | DOID:1459 (biomarker_via_orthology) | |
| Disease | Fatty Liver | 3.09e-03 | 88 | 97 | 3 | C0015695 | |
| Disease | Steatohepatitis | 3.09e-03 | 88 | 97 | 3 | C2711227 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GLSGIGAFRGMCTPH | 296 | Q9UKF5 | |
| GAFRGMCTPHRSCAI | 301 | Q9UKF5 | |
| HVAPMARCAAGAASG | 1196 | Q9BZ76 | |
| TFLGSHMFSCCPEGR | 291 | P41214 | |
| MPGGAGAARLCLLAF | 1 | Q9H013 | |
| ADGGCIMAAATGHPF | 366 | Q9H013 | |
| GVGCIHYEMATGRPL | 326 | Q07002 | |
| GESVGHCPSCQRLFM | 16 | O95833 | |
| NTIPGHGGIMDRFDC | 371 | O95674 | |
| LGCPQMIAKRGHYGA | 106 | Q6P1R4 | |
| PGGHRCLCYDGFMAT | 1216 | Q75N90 | |
| HCCKPGGRLDMNHGF | 11 | Q2NKX9 | |
| CPHMATCGNVLFEGR | 571 | Q9UPW5 | |
| LGHPFGATGCRLVMA | 426 | P55084 | |
| GHMPFRTGTGDIATC | 1311 | Q9NZN5 | |
| GVGATFPGALPCHMC | 5531 | Q9HC84 | |
| FVSRPCLNGGTCHML | 71 | Q7Z3S9 | |
| SGYFVLGHPMCVLEG | 116 | P04000 | |
| EHNTIGFMFACVGRG | 316 | Q8NEZ5 | |
| FGMARGLCTSPAEHQ | 201 | Q13164 | |
| GGFTCLCMPGFKGVH | 476 | Q04721 | |
| RGPHCLNGGQCMDRI | 1231 | Q04721 | |
| SCFHRIIPGFMCQGG | 51 | A0A0B4J2A2 | |
| LAGGSLLMHCPCYGS | 601 | Q96RG2 | |
| RPIHCGVRFGAGCGM | 71 | Q9NSB2 | |
| VMGHTGGLGCPFDRL | 216 | A6NDP7 | |
| MLCPRAAFLVGSFHG | 1 | Q8WZ33 | |
| FAGNACVAMPHKIGR | 1026 | Q96QZ7 | |
| MCEGCRSLAAGHPGY | 81 | Q8NFG4 | |
| RCGVHPGPGTFLFMG | 241 | Q9UJH8 | |
| CVNRFGCRPVMLVGG | 81 | O15427 | |
| CGGLRHPNCMLVNIG | 881 | P59045 | |
| SCNPSFGGIGKGHLM | 76 | Q9Y2Z2 | |
| NGCTPLHLAAGRGLM | 436 | O00221 | |
| RHGFCGIPITDTGRM | 136 | P12268 | |
| HFLGGCMVFFGLCPL | 111 | P34995 | |
| CGGANPLMKLAGHFT | 11 | P50542 | |
| RMLFGASAGALHCVG | 41 | Q9NST1 | |
| GFLAHPSRTEGCMFE | 281 | P50549 | |
| ISVGGMCICYGHARA | 281 | P24043 | |
| GCGIQMFFHLTLAGA | 101 | Q8NGX1 | |
| SCFHRIIPGFMCQGG | 51 | P0DN26 | |
| LAGCGNAAIHTGMTF | 156 | Q8NGF4 | |
| GACHGQTGMFPRNYV | 196 | P62993 | |
| FVSRPCLNGGTCHML | 71 | P0DPK4 | |
| SCFHRIIPGFMCQGG | 51 | A0A075B759 | |
| RFCDSPDGVMLCGSH | 2721 | P78509 | |
| LGAHPHGIMCTGFLC | 111 | Q86VF5 | |
| SCFHRIIPGFMCQGG | 51 | F5H284 | |
| SCFHRIIPGFMCQGG | 51 | A0A075B767 | |
| SCFHRIIPGFMCQGG | 51 | Q9Y536 | |
| IIPGFMCQGGDFTRH | 56 | Q9Y536 | |
| SCFHRIIPGFMCQGG | 51 | P0DN37 | |
| IIPGFMCQGGDFTHP | 56 | P0DN37 | |
| FLVFMSHGIREGICG | 231 | P29466 | |
| GYCMGIGPLISHGRF | 51 | P11511 | |
| PGYFRIGQGHCVSGM | 2676 | P35555 | |
| LGGSGADHMPLNCFI | 701 | Q9P2H0 | |
| NRGGKPLIMYSCHGL | 516 | Q8NCL4 | |
| FVELGPCHRMGGNQL | 556 | Q86SF2 | |
| RGPCMLCFIVHSPGA | 56 | Q9UF56 | |
| FRCQPGFGMKGPSHV | 256 | Q2VPA4 | |
| GSYRCVLGCQPGFHM | 1281 | Q14767 | |
| RGDVFSPPGMVHGQC | 281 | A4D0S4 | |
| GVMGDKCDRCQPGFH | 421 | P11047 | |
| GCLLMGLPCGHVFHQ | 631 | O00237 | |
| EGRLVNLGCAMGHPS | 341 | P23526 | |
| HVAPMARCAAGAASG | 1196 | Q96NU0 | |
| HPHGIMGLGAFCNFS | 161 | Q96PD7 | |
| CGGEMFDVPCSRVGH | 351 | Q49A17 | |
| VCVGIMAACPSGHAA | 281 | P59533 | |
| LCQSHGGGAFMIPFL | 61 | Q695T7 | |
| HLTRVTPMGGGCLAQ | 91 | Q8NEQ6 | |
| SCFHRIIPGFMCQGG | 51 | P62937 | |
| IIPGFMCQGGDFTRH | 56 | P62937 | |
| MFLLPASGGPCCSHA | 371 | Q8N205 | |
| GRGAPGAACRHMDIF | 186 | Q96AM1 | |
| CGAIGHMRTNKFCPL | 1286 | Q8IZX4 | |
| ACGAIGHMRTNKFCP | 1266 | P21675 | |
| NCGAFGHMARSTRCP | 46 | D6RGX4 | |
| HFGFPGSGGLCTLVM | 356 | Q86UD5 | |
| LQDGATGLCLPGRHM | 1121 | Q6ZUB1 | |
| GDGRIMIGFSCGHFV | 241 | Q8NEZ3 | |
| FIGMSPCVGVSGNHT | 1686 | P08F94 | |
| RFGMHFCGGTLISPE | 601 | P00747 | |
| CFIMGIGGVLTALPH | 101 | Q9Y6L6 | |
| CQDFMLHGAVSLPGG | 221 | O75339 | |
| MAGLQPGGHTAVGIC | 471 | Q9H2X0 | |
| AVGICPGLGARGAHM | 481 | Q9H2X0 | |
| RMIGLFSHGFLAGCA | 226 | Q96Q45 | |
| GGVSVRLAAFGHMLC | 541 | Q15735 | |
| CCHRPAGRGAMQSVL | 11 | O60907 | |
| LAHLAGMGGSPVERC | 1806 | Q63HN8 | |
| IFQGQRHCPGGEGMF | 76 | Q6RFH5 | |
| RHCPGGEGMFRGLAQ | 81 | Q6RFH5 | |
| SAMAVCFGPAALGHL | 886 | Q96KV7 | |
| FPGGGMEAQHVTLCL | 16 | P52747 | |
| MRFCGHLAAVGGAVG | 541 | Q9ULX5 | |
| AMERGSHFSLGCPQL | 586 | Q9NRA0 | |
| RIFGLPGGNIFHCAM | 511 | Q8N2H3 | |
| RGHCGPCRFRGFEVM | 31 | Q96DB5 | |
| DCLQCFFIIHSMGGG | 136 | Q9UJT0 | |
| SIAGGEHLCFMGSGR | 391 | Q9NUY8 | |
| PHGNRFMVGCGRCDD | 726 | Q92576 | |
| GLAFCAEMGLPHRGY | 96 | Q9P273 | |
| GGFCNFMHLKPISRE | 166 | Q01081 | |
| GECTRGGFCNFMHLR | 161 | Q8WU68 | |
| GDLNRFPCGMEVHSG | 726 | A8K0R7 | |
| MFLHSGPARGPCTAA | 1 | Q96MT0 | |
| LGPEMTVLFAHRSGC | 681 | Q8TEC5 | |
| HAVDPGCRLCRFMGV | 96 | P21731 | |
| HFLGLGAPNCLSMGS | 216 | O96006 | |
| NSALLCPHGGLMFTF | 771 | Q86UV5 | |
| CGCKVPMISGRGLGH | 136 | P19971 | |
| CCMGIDSILGHPFAA | 836 | Q9ULE0 | |
| AAQLGCCHRPMALGG | 6 | Q8IZ20 | |
| CCHRPMALGGTGGSL | 11 | Q8IZ20 | |
| MFGFPTATLLDCHGR | 1 | P17041 |